Skip to main navigation

Back

Contact Revance
Login

Menu

Aesthetics
Back Aesthetics
Visit Site
Therapeutics
Back Therapeutics
Investors
Back Investors
LATEST NEWS
In the News

April 27, 2021

Experts Call These the Most Cutting-Edge Aesthetic Treatments

InStyle

All News
Company
Back Company
OUR LATEST
In the News

April 27, 2021

Experts Call These the Most Cutting-Edge Aesthetic Treatments

InStyle

Our Latest
News
Careers
Back Careers

facebook
instagram
twitter
linkedin

1222 Demonbreun St
20th Floor
Nashville, TN 37203

Contact Revance
Login

© Copyright 2021

All Rights Reserved

Breadcrumb

Home
Investors
Press releases

Press Releases

Press Releases

Items Per Page

Year

November 19, 2021

Revance to Present Clinical Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Filler Injection Technique at the 2021 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting

November 18, 2021

Revance to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 10, 2021

Revance to Participate in the Stifel 2021 Virtual Healthcare Conference

November 9, 2021

Revance Reports Third Quarter 2021 Financial Results, Provides Corporate Update

November 2, 2021

Revance to Release Third Quarter 2021 Financial Results on Tuesday, November 9, 2021

October 15, 2021

Revance Provides Regulatory Update on DaxibotulinumtoxinA for Injection for the Treatment of Moderate to Severe Glabellar (Frown) Lines

October 12, 2021

Revance Continues to Anticipate FDA Approval of DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines in 2021

October 11, 2021

Revance Announces the Launch of OPUL™, the First-of-its-Kind Relational Commerce Platform for Aesthetic Practices

September 16, 2021

Revance to Showcase Data from Phase 3 ASPEN-1 Clinical Trial Evaluating Efficacy, Duration of Effect and Safety of DaxibotulinumtoxinA for Injection for Cervical Dystonia at International Parkinson and Movement Disorder Society Virtual Congress 2021

September 10, 2021

Revance Presents Data on the RHA® Collection of Dermal Fillers at the 2021 Virtual Skin of Color Update Meeting

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 1 - 10 of 266

Investor Relations

Investor Relations
Press Releases
Events & Presentations
- Events
- Presentations and Corporate Materials
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQs
Contact Us

image description

Revance - Shareholder Tools

Print Page
Printed Materials
Email Alerts
Download Library
RSS News Feeds
Share
Search

Keep up with Revance

Subscribe

1222 Demonbreun St
20th Floor
Nashville, TN 37203

facebook
instagram
twitter
linkedin

Aesthetics

Overview
RHA®
OPUL
Neuromodulator
Neuromodulator Uses
Clinical Highlights

Therapeutics

Overview
Cervical Dystonia
Upper Limb Spasticity
Plantar Fasciitis
Clinical Highlights

Investors

Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQ
Contact Us

Company

Overview
About Revance
Leadership Team
Board of Directors
Partnerships
Investigator Sponsored Trials
Medical Education Grants
Sustainability
Contact Revance

News

All News
In the News
Our Latest

Careers

Overview
Career Opportunities
Culture
Benefits & Perks

© Copyright 2021
All Rights Reserved
Terms of Use
Privacy Policy
Corporate Social Media Community Guidelines

Facebook
LinkedIn